Furthermore, higher levels of interleukin receptor antagonist (IL-RA), a highly competitive antagonist of the proinflammatory cytokine IL-1, have been found in AMS-resistant subjects but not in AMS-sensitive subjects (Julian et al., 2011). This evidence concerns the gene IL7R and ablepharon macrostomia syndrome.